The Efficacy and Safety of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Combined With Thymosin in Advanced Non-Small Cell Lung Cancer Patients Harboring Active Epidermal Growth Factor Receptor Mutations

Benzer Materyaller

• Comparison of epidermal growth factor receptor tyrosine kinase inhibitors for patients with lung adenocarcinoma harboring different epidermal growth factor receptor mutation types
  Yazar:: Park, Sojung, ve diğerleri
  Baskı/Yayın Bilgisi: (2021)
• Aspirin inhibits lipopolysaccharide-induced COX-2 expression and PGE(2) production in porcine alveolar macrophages by modulating protein kinase C and protein tyrosine phosphatase activity
  Yazar:: Duan, Yuzhong, ve diğerleri
  Baskı/Yayın Bilgisi: (2014)
• Epidermal growth factor receptor tyrosine kinase inhibitors
  Yazar:: Ranson, M
  Baskı/Yayın Bilgisi: (2004)
• Hepatocyte growth factor reduces sensitivity to the epidermal growth factor receptor-tyrosine kinase inhibitor, gefitinib, in lung adenocarcinoma cells harboring wild-type EGFR
  Yazar:: Yang, Hua, ve diğerleri
  Baskı/Yayın Bilgisi: (2016)
• The Role of Epidermal Growth Factor Receptor Mutations and Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in the Treatment of Lung Cancer
  Yazar:: Chang, Shih-Chieh, ve diğerleri
  Baskı/Yayın Bilgisi: (2011)